North America cholesterol testing Market Analysis, Companies Profiles, Size, Share, Growth, Trends and Forecast to 2024

North America cholesterol testing Market Analysis, Companies Profiles, Size, Share, Growth, Trends and Forecast to 2024


  • Products Id :- DBMR45
  • |
  • Pages: 118
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

North America cholesterol testing market is expected to reach USD 4,437.81 million by 2025, from USD 2,491.51 million in 2017 growing at a CAGR of 7.6% in the forecast period 2018 to 2025.

The major factors driving the market are technological advancements in cholesterol testing, growing number of cardiovascular diseases and obesity, higher growing number of geriatric population, rising awareness and acceptance of preventive healthcare, increasing cholesterol home/self-testing market. The cholesterol testing market in the North America region is leading in US.

The key market players for North America Cholesterol Testing Market are listed below:

Abbott Laboratories

Accutech, LLC

Beckman Coulter, Inc.

Bio-Rad Laboratories, Inc.

Prima Lab SA

Quest Diagnostics, Inc.

Home Access Health Corporation

F. Hoffmann-La Roche AG

Siemens AG

Sigma-Aldrich Corp.

The market is further segmented into:

Product Type

Test

Test Type

Prescription Mode

End-users

The North America cholesterol testing market is segmented on the basis of product type, test, test type, prescription mode, and end-users. The report provides data for 2016 to 2025, 2017 being the current year while 2018 to 2025 is the forecast period for the report.

The North America cholesterol testing market is segmented based on product type into testing strips and test kits. In 2018, test kits segment is expected to dominate the North America cholesterol testing market with 55.3% market share and is expected to reach USD 2,494.82 million by 2025, growing at the highest CAGR of 7.8% in the forecast period 2018 to 2025.

The North America cholesterol testing market is segmented on the basis of test into lipid panel test/complete lipid profile, apolipoprotein b test, apolipoprotein A-1 test, APOE genotyping test, apolipoprotein CII and others. In 2018, lipid panel test/complete lipid profile segment is expected to dominate the North America cholesterol testing market with 28.4% market share and is expected to reach USD 1,301.88 million by 2025, growing at the highest CAGR of 8.1% in the forecast period 2018 to 2025.

The North America cholesterol testing market is segmented on the basis of test type into non-invasive and invasive. In 2018, invasive market segment is expected to dominate the North America cholesterol testing market with 67.6% market share and is expected to reach USD 2,946.36 million by 2025, growing at a CAGR of 7.3% in the forecast period 2018 to 2025. However, non-invasive is expected to grow at the highest CAGR of 8.1% in the forecast period, and is expected to reach USD 1,491.45 million in 2025 from USD 804.30 million in 2017.

The North America cholesterol testing market is segmented on the basis of prescription mode into over the counter and prescription based. In 2018, prescription based market segment is expected to dominate the North America cholesterol testing market with 75.1% market share and is expected to reach USD 3,397.96 million by 2025, growing at the highest CAGR of 7.9% in the forecast period 2018 to 2025.

The North America cholesterol testing market is segmented on the basis of prescription mode into end users, clinics, hospitals, ambulatory centers, homecare and diagnostic centers. In 2018, hospitals are expected to dominate the North America cholesterol testing market with 31.6% market share and are expected to reach USD 1,497.23 million by 2025, growing at the highest CAGR of 8.6% in the forecast period 2018 to 2025.

.Based on geography, the North America cholesterol testing market is segmented into geographical regions, such as,

U.S.

Canada

Mexico

Covered in this report

The report covers the present scenario and the growth prospects of the North America cholesterol testing market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of the web conferencing and unified communication and collaboration (UC&C) and video conferencing, secondary resources and doing in-depth company share analysis of major 10 players in the market.

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

TABLE OF CONTENTS

1. INTRODUCTION 15

1.1. OBJECTIVES OF THE STUDY 15

1.2. MARKET DEFINITION 15

1.3. OVERVIEW OF NORTH AMERICA CHOLESTEROL TESTING MARKET 15

1.4. CURRENCY AND PRICING 16

1.5. LIMITATION 16

1.6. MARKETS COVERED 17

2. MARKET SEGMENTATION 19

2.1. MARKETS COVERED 19

2.2. GEOGRAPHIC SCOPE 20

2.3. YEARS CONSIDERED FOR THE STUDY 21

2.4. CURRENCY AND PRICING 21

2.5. RESEARCH METHODOLOGY 22

2.6. PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 25

2.7. SECONDARY SOURCES 26

2.8. ASSUMPTIONS 27

3. EXECUTIVE SUMMARY 28

4. MARKET OVERVIEW 31

4.1. DRIVERS 33

4.2. RESTRAINTS 34

4.3. OPPORTUNITIES 35

4.4. CHALLENGES 35

5. PREMIUM INSIGHTS 36

6. NORTH AMERICA CHOLESTEROL TESTING MARKET, BY PRODUCT TYPE 37

6.1. OVERVIEW 38

6.2. TESTING STRIPS 40

6.3. TEST KITS 41

7. NORTH AMERICA CHOLESTEROL TESTING MARKET, BY TEST 42

7.1. OVERVIEW 43

7.2. LIPID PANEL TEST/COMPLETE LIPID PROFILE 45

7.2.1. TOTAL CHOLESTEROL TEST 46

7.2.2. HDL CHOLESTEROL TEST 46

7.2.3. LDL CHOLESTEROL TEST 47

7.2.4. TRIGLYCERIDES/VLDL CHOLESTEROL TEST 47

7.3. APOLIPOPROTEIN B TEST 48

7.4. APOLIPOPROTEIN A-1 TEST 49

7.5. APOE GENOTYPING TEST 50

7.6. APOLIPOPROTEIN CII 51

7.7. OTHERS 52

8. NORTH AMERICA CHOLESTEROL TESTING MARKET, BY TEST TYPE 53

8.1. OVERVIEW 54

8.2. NON-INVASIVE 56

8.3. INVASIVE 57

9. NORTH AMERICA CHOLESTEROL TESTING MARKET, BY PRESCRIPTION MODE 58

9.1. OVERVIEW 59

9.2. OVER THE COUNTER 61

9.3. PRESCRIPTION BASED 62

10. NORTH AMERICA CHOLESTEROL TESTING MARKET, BY END-USERS 63

10.1. OVERVIEW 64

10.2. CLINICS 66

10.3. HOSPITALS 67

10.4. AMBULATORY CENTERS 68

10.5. HOMECARE 69

10.6. DIAGNOSTIC CENTERS 70

11. NORTH AMERICA CHOLESTEROL TESTING MARKET BY GEOGRAPHY 71

11.1. NORTH AMERICA 73

11.1.1. U.S. 83

11.1.2. CANADA 86

11.1.3. MEXICO 89

12. NORTH AMERICA CHOLESTEROL TESTING MARKET, COMPANY LANDSCAPE 93

12.1. COMPANY SHARE ANALYSIS: NORTH AMERICA 93

13. COMPANY PROFILES 94

13.1. BIO-RAD LABORATORIES, INC. 94

13.1.1. COMPANY OVERVIEW 94

13.1.2. BIO-RAD LABORATORIES, INC.: REVENUE ANALYSIS 94

13.1.3. PRODUCT PORTFOLIO 95

13.1.4. RECENT DEVELOPMENTS 95

13.2. ABBOTT 96

13.2.1. COMPANY OVERVIEW 96

13.2.2. ABBOTT: REVENUE ANALYSIS 96

13.2.3. PRODUCT PORTFOLIO 97

13.2.4. RECENT DEVELOPMENTS 97

13.3. SIEMENS AG 98

13.3.1. COMPANY OVERVIEW 98

13.3.2. SIEMENS AG: REVENUE ANALYSIS 98

13.3.3. PRODUCT PORTFOLIO 99

13.3.4. RECENT DEVELOPMENTS 99

13.4. ALERE INC. 100

13.4.1. COMPANY OVERVIEW 100

13.4.2. ALERE INC.: REVENUE ANALYSIS 100

13.4.3. PRODUCT PORTFOLIO 101

13.4.4. RECENT DEVELOPMENTS 101

13.5. SIGMA ALDRICH (A SUBSIDIARY OF MERCK KGAA) 102

13.5.1. COMPANY OVERVIEW 102

13.5.2. MERCK KGAA: REVENUE ANALYSIS 102

13.5.3. PRODUCT PORTFOLIO 103

13.5.4. RECENT DEVELOPMENTS 103

13.6. F. HOFFMANN-LA ROCHE LTD 104

13.6.1. COMPANY OVERVIEW 104

13.6.2. F. HOFFMANN-LA ROCHE LTD:REVENUE ANALYSIS 104

13.6.3. PRODUCT PORTFOLIO 105

13.6.4. RECENT DEVELOPMENTS 105

13.7. DANAHER 106

13.7.1. COMPANY OVERVIEW 106

13.7.2. DANAHER: REVENUE ANALYSIS 106

13.7.3. PRODUCT PORTFOLIO 107

13.7.4. RECENT DEVELOPMENTS 107

13.8. QUEST DIAGNOSTICS INCORPORATED 108

13.8.1. COMPANY OVERVIEW 108

13.8.2. QUEST DIAGNOSTICS INCORPORATED: REVENUE ANALYSIS 108

13.8.3. PRODUCT PORTFOLIO 109

13.8.4. RECENT DEVELOPMENTS 109

13.9. ACCUTECH, LLC 110

13.9.1. COMPANY OVERVIEW 110

13.9.2. ACCUTECH, LLC: COMPANY SNAPSHOT 110

13.9.3. PRODUCT PORTFOLIO 110

13.9.4. RECENT DEVELOPMENTS 110

13.10. PRIMA LAB SA 111

13.10.1. COMPANY OVERVIEW 111

13.10.2. PRIMA LAB SA: COMPANY SNAPSHOT 111

13.10.3. PRODUCT PORTFOLIO 111

13.10.4. RECENT DEVELOPMENTS 111

13.11. HOME ACCESS HEALTH CORPORATION 112

13.11.1. COMPANY OVERVIEW 112

13.11.2. HOME ACCESS HEALTH CORPORATION: COMPANY SNAPSHOT 112

13.11.3. PRODUCT PORTFOLIO 112

13.11.4. RECENT DEVELOPMENTS 112

13.12. EUROFINS SCIENTIFIC 113

13.12.1. COMPANY OVERVIEW 113

13.12.2. EUROFINS SCIENTIFIC: REVENUE ANALYSIS 113

13.12.3. PRODUCT PORTFOLIO 114

13.12.4. RECENT DEVELOPMENTS 114

13.13. RANDOX LABORATORIES LTD. 115

13.13.1. COMPANY OVERVIEW 115

13.13.2. RANDOX LABORATORIES LTD.: COMPANY SNAPSHOT 115

13.13.3. PRODUCT PORTFOLIO 115

13.13.4. RECENT DEVELOPMENTS 115

13.14. PTS DIAGNOSTICS 116

13.14.1. COMPANY OVERVIEW 116

13.14.2. PTS DIAGNOSTIC: COMPANY SNAPSHOT 116

13.14.3. PRODUCT PORTFOLIO 117

13.14.4. RECENT DEVELOPMENTS 117

14. RELATED REPORTS 118

Figures List

Figure 1 North America Cholesterol Testing Market : Segmentation 20

Figure 2 North America Cholesterol Testing Market: Data Triangulation 23

Figure 3 North America Cholesterol Testing Market: Research Snapshot 24

Figure 4 North America Cholesterol Testing Market : Bottom Up Approach 25

Figure 5 North America Cholesterol Testing Market : Top Down Approach 25

Figure 6 North America Cholesterol Testing Market: Interview Demographics 26

Figure 7 North America Cholesterol Testing Market: Segmentation 30

Figure 8 North America Is Expected To Dominate The Market For Cholesterol Testing And Asia Pacific Is Expected To Be Growing With The Highest Cagr In The Forecast Period From 2018 To 2025 31

Figure 9 Drivers, Restraints, Opportunities, And Challenges Of North America Cholesterol Testing Market 33

Figure 10 North America Cholesterol Testing Market: By Product Type, 2017 39

Figure 11 North America Cholesterol Testing Market: By Test, 2017 44

Figure 12 North America Cholesterol Testing Market: By Test Type, 2017 55

Figure 13 North America Cholesterol Testing Market: By Prescription Mode, 2017 60

Figure 14 North America Cholesterol Testing Market: By End-Users, 2017 65

Figure 15 North America Cholesterol Testing Market : Snapshot (2017) 75

Figure 16 North America Cholesterol Testing Market: By Country (2017) 76

Figure 17 North America Cholesterol Testing Market: By Country (2018 & 2025) 77

Figure 18 North America Cholesterol Testing Market, By Country (2017 & 2025) 78

Figure 19 North America Cholesterol Testing Market, By Product Type (2018 & 2025) 79

Figure 20 North America Cholesterol Testing Market: Company Share 2017 (%) 94

Figure 21 North America Cholesterol Testing Market: Company Share 2017 (%) 95

Figure 22 Europe Cholesterol Testing Market: Company Share 2017 (%) 96

Figure 23 Asia Pacific Cholesterol Testing Market: Company Share 2017 (%) 97

Table List

Table 1 North America Cholesterol Testing Market, By Product Type, 2016- 2025 (Usd Million) 41

Table 2 North America Cholesterol Testing Market, Testing Strips, 2016-2025 (Usd Million) 42

Table 3 North America Cholesterol Testing Market,Test Kits, 2016-2025 (Usd Million) 43

Table 4 North America Cholesterol Testing Market, By Test, 2016 -2025 (Usd Million) 46

Table 5 North America Lipid Panel Test/Complete Lipid Profile Market, By Type, 2016-2025 (Usd Million) 47

Table 6 North America Cholesterol Testing Market, Lipid Panel Test/Complete Lipid Profile, 2016-2025 (Usd Million) 48

Table 7 North America Cholesterol Testing Market, Apolipoprotein B Test, Region, 2016-2025 (Usd Million) 50

Table 8 North America Cholesterol Testing Market, Apolipoprotein A-1 Test, Region, 2016-2025 (Usd Million) 51

Table 9 North America Cholesterol Testing Market, Apoe Genotyping Test, Region, 2016-2025 (Usd Million) 52

Table 10 North America Cholesterol Testing Market, Apolipoprotein Cii, Region, 2016-2025 (Usd Million) 53

Table 11 North America Cholesterol Testing Market, Others, 2016-2025 (Usd Million) 54

Table 12 North America Cholesterol Testing Market, By Test Type, 2016-2025 (Usd Million) 57

Table 13 North America Cholesterol Testing Market, Non-Invasive, 2016-2025 (Usd Million) 58

Table 14 North America Cholesterol Testing Market, Invasive, Region, 2016-2025 (Usd Million) 59

Table 15 North America Cholesterol Testing Market, By Prescription Mode, 2016-2025 (Usd Million) 62

Table 16 North America Cholesterol Testing Market, Over The Counter, 2016-2025 (Usd Million) 63

Table 17 North America Cholesterol Testing Market, Prescription Based, 2016-2025 (Usd Million) 64

Table 18 North America Cholesterol Testing Market, By End-Users, 2016-2025 (Usd Million) 67

Table 19 North America Cholesterol Testing Market, Clinics, 2016-2025 (Usd Million) 68

Table 20 North America Cholesterol Testing Market, Hospitals, 2016-2025 (Usd Million) 69

Table 21 North America Cholesterol Testing Market, Ambulatory Centers, 2016-2025 (Usd Million) 70

Table 22 North America Cholesterol Testing Market, Homecare, 2016-2025 (Usd Million) 71

Table 23 North America Cholesterol Testing Market, Diagnostic Centers, 2016-2025 (Usd Million) 72

Table 24 North America Cholesterol Testing Market, By Country, 2016-2025 (Usd Million), 81

Table 25 North America Cholesterol Testing Market, By Product Type, 2016-2025 (Usd Million) 81

Table 26 North America Cholesterol Testing Market, By Test, 2016-2025 (Usd Million) 82

Table 27 North America Lipid Panel Test/Complete Lipid Profile Market, By Type, 2016-2025 (Usd Million) 82

Table 28 North America Cholesterol Testing Market, By Test Type, 2016-2025 (Usd Million) 83

Table 29 North America Cholesterol Testing Market, By Prescription Mode, 2016-2025 (Usd Million) 83

Table 30 North America Cholesterol Testing Market, By End Users, 2016-2025 (Usd Million) 84

Table 31 U.S. Cholesterol Testing Market, By Product Type, 2016-2025 (Usd Million) 85

Table 32 U.S.Cholesterol Testing Market, By Test, 2016-2025 (Usd Million) 85

Table 33 U.S. Lipid Panel Test/Complete Lipid Profile Market, By Type, 2016-2025 (Usd Million) 86

Table 34 U.S. Cholesterol Testing Market, By Test Type, 2016-2025 (Usd Million) 86

Table 35 U.S. Cholesterol Testing Market, By Prescription Mode, 2016-2025 (Usd Million) 87

Table 36 U.S. Cholesterol Testing Market, By End Users, 2016-2025 (Usd Million) 87

Table 37 Canada Cholesterol Testing Market, By Product Type, 2016-2025 (Usd Million) 88

Table 38 Canada Cholesterol Testing Market, By Test, 2016-2025 (Usd Million) 88

Table 39 Canada Lipid Panel Test/Complete Lipid Profile Market, By Type, 2016-2025 (Usd Million) 89

Table 40 Canada Cholesterol Testing Market, By Test Type, 2016-2025 (Usd Million) 89

Table 41 Canada Cholesterol Testing Market, By Prescription Mode, 2016-2025 (Usd Million) 90

Table 42 Canada Cholesterol Testing Market, By End Users, 2016-2025 (Usd Million) 90

Table 43 Mexico Cholesterol Testing Market, By Product Type, 2016-2025 (Usd Million) 91

Table 44 Mexico Cholesterol Testing Market, By Test, 2016-2025 (Usd Million) 91

Table 45 Mexico Lipid Panel Test/Complete Lipid Profile Market, By Type, 2016-2025 (Usd Million) 92

Table 46 Mexico Cholesterol Testing Market, By Test Type, 2016-2025 (Usd Million) 92

Table 47 Mexico Cholesterol Testing Market, By Prescription Mode, 2016-2025 (Usd Million) 93

Table 48 Mexico Cholesterol Testing Market, By End Users, 2016-2025 (Usd Million) 93

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

Abbott Laboratories

Accutech, LLC

Beckman Coulter, Inc.

Bio-Rad Laboratories, Inc.

Prima Lab SA

Quest Diagnostics, Inc.

Home Access Health Corporation

F. Hoffmann-La Roche AG

Siemens AG

Sigma-Aldrich Corp.

select a license
Single User License
USD 4200 INR 299796
Corporate User License
USD 5400 INR 385452

NEWSLETTER BY CATEGORY




Testimonials

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...

An excellent provider. Thorough, precise and outstanding insight. They drill down to what we need and their reports are effective at integrating text with supporting graphics and charts. Their reports are a great resource to go back too. ...

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process....

Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed...



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com